Tag: ASH 2019

19-CNR-6810 QD ASH Top 10 Twitter
January 23, 2020/Research

Top 10 Takeaways from ASH 2019

These research results will have impact in 2020

T-cells_650x450
December 9, 2019/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

QD-Myelofibrosis-GERDS
December 9, 2019/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-African-American-Patient-2
December 8, 2019/Research

Studies’ Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials

Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes

BackPage 1 of 1Next
Advertisement
Ad